Lululemon's Stock Continues to Be a Lemon. Can the Stock Rebound, or Should Investors Stay Away?

Lululemon's shares plunged following its fiscal Q2 report and a significant cut to full-year guidance, primarily due to intensified competition, product line staleness, and anticipated tariff impacts, despite revenue growing 7% to $2.53 billion and adjusted EPS of $3.10 exceeding analyst estimates. While North American operations softened with a 4% decline in same-store sales, international revenue surged 22%, led by a 25% increase in China. The company is addressing challenges through accelerated innovation and design, and its stock now trades at an attractive forward P/E of approximately 11x, presenting a potential value opportunity despite rising inventory levels and a challenging domestic market.

Analysis

Lululemon Athletica (LULU) is facing significant headwinds, evidenced by a stock price decline of over 50% in 2025 and a substantial downward revision of its full-year guidance. While fiscal Q2 revenue grew 7% year-over-year to $2.53 billion and adjusted EPS of $3.10 beat analyst expectations, the positive results were overshadowed by a deteriorating outlook. Management acknowledged strategic missteps, including stale product lines in an increasingly competitive environment. This is reflected in the divergent geographical performance: North American revenue increased just 1% with a 4% decline in same-store sales, whereas international revenue surged 22%, driven by 25% growth in China. Key metrics signal potential future pressure, as gross margin compressed by 110 basis points to 58.5% and inventory levels rose 21%. The company slashed its full-year adjusted EPS forecast from a midpoint of $14.68 to $12.82, citing both operational challenges and the anticipated impact of tariffs. Despite these issues, the company is implementing a turnaround strategy focused on faster innovation and is still commanding strong margins relative to peers. The stock's valuation has subsequently compressed to a forward P/E of approximately 11, a steep discount to competitor Nike's multiple of around 30.

Key Decisions for Investors

• Investors should closely monitor key risk indicators such as the 21% increase in inventory and further gross margin compression, as these could signal forced markdowns and weakening pricing power.
• The primary investment thesis hinges on balancing the significant slowdown in the core North American market against the robust international growth engine, particularly in China where revenue grew 25%, and the potential success of management's product innovation turnaround.
• Given the stock's re-rating to a forward P/E of approximately 11x, the current valuation may present a compelling entry point for value-oriented investors, but this must be weighed against the considerable execution risk of reviving growth in a competitive domestic market.